NH HB1117

Protects licensed health care providers from disciplinary action, professional sanctions, or civil/criminal liability for communicating in good faith about emerging medical research, experimental treatments, innovative therapies, or off-label medication uses

Allows providers to recommend or prescribe therapies outside the current standard of care if they reasonably believe it may benefit the patient, the patient gives informed consent, and the therapy is not prohibited by law

Prohibits retaliation from state licensing boards, employers, or insurers against providers exercising these communication rights

Creates a civil cause of action allowing aggrieved health care providers to seek injunctive relief, reinstatement, damages, or other remedies

Takes effect 60 days after passage with no estimated fiscal impact on state revenue or expenditures